# Nicotinamide Riboside Promotes Sir2 Silencing and Extends Lifespan via Nrk and Urh1/Pnp1/Meu1 Pathways to NAD+

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/nicotinamide-riboside-promotes-sir2-silencing-and-extends-lifespan-via-nrk-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Peter Belenky,Frances G. Racette,Katrina L. Bogan,Julie M. McClure,Jeffrey S. Smith,Charles Brenner |
| Citations | 415 |
| DOI | 10.1016/j.cell.2007.03.024 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.cell.com/article/S009286740700390X/pdf |
| OpenAlex ID | https://openalex.org/W2168486424 |
| PMID | 17482543 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Charles Brenner](https://scholariq.org/researchers/charles-brenner/)

## Paper primary topic

- [Sirtuins and Resveratrol in Medicine](https://scholariq.org/topics/sirtuins-and-resveratrol-in-medicine/)

## Paper topics

- [Sirtuins and Resveratrol in Medicine](https://scholariq.org/topics/sirtuins-and-resveratrol-in-medicine/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Adipose Tissue and Metabolism](https://scholariq.org/topics/adipose-tissue-and-metabolism/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.